# Ernexa Therapeutics Inc.: Form 8-K/A, filed Jun 13, 2013

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: 8-K/A
- Filed: 2013-06-13
- Accepted by EDGAR: Jun 13, 2013, 16:44 ET
- Period: 2013-06-07
- Accession: 0001019687-13-002331
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000101968713002331/ntn_8ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000101968713002331/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000101968713002331/ntn_8ka.htm

Filed Jun 13, 2013.
Source: SEC EDGAR, the filing index for accession 0001019687-13-002331. Last ingested by Listed: Nov 11, 2026, 02:49 ET. No prices; not investment advice.